BRUKER CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
BRUKER CORPORATION (BRKR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 1.80% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-02-27
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 1.80%, a 45.45% decline from fiscal 2024.
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was 3.30%, a 57.14% increase from fiscal 2023.
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was 2.10%, a 90.91% increase from fiscal 2022.
- BRUKER CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2022 was 1.10%, a 8.33% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.80% 10-K · filed 2026-02-27 | |
| 2024-12-31 | 3.30% 10-K · filed 2026-02-27 | |
| 2023-12-31 | 2.10% 10-K · filed 2026-02-27 | 2.80% 10-K · filed 2024-02-29 |
| 2022-12-31 | 1.10% 10-K · filed 2025-03-03 | |
| 2021-12-31 | 1.20% 10-K · filed 2024-02-29 | |
| 2020-12-31 | 2.00% 10-K · filed 2023-03-01 | 1.60% 10-K · filed 2021-03-01 |
| 2019-12-31 | 0.70% 10-K · filed 2022-02-28 | 1.10% 10-K · filed 2021-03-01 |
| 2018-12-31 | 0.70% 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |